```

[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[S. 3831 Introduced in Senate (IS)]

<DOC>

117th CONGRESS
  2d Session
                                S. 3831

    To require the National Academies of Sciences, Engineering, and 
  Medicine to conduct a study relating to COVID-19 immunity resulting 
    from a prior infection, vaccination, or both, and the COVID-19 
                               pandemic.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             March 14, 2022

Mr. Braun (for himself and Mr. Marshall) introduced the following bill; 
     which was read twice and referred to the Committee on Health, 
                     Education, Labor, and Pensions

_______________________________________________________________________

                                 A BILL

 
    To require the National Academies of Sciences, Engineering, and 
  Medicine to conduct a study relating to COVID-19 immunity resulting 
    from a prior infection, vaccination, or both, and the COVID-19 
                               pandemic.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Apply the Science Act 2.0''.

SEC. 2. NATIONAL ACADEMIES OF SCIENCES, ENGINEERING, AND MEDICINE STUDY 
              ON NATURAL IMMUNITY IN RELATION TO THE COVID-19 PANDEMIC.

    (a) In General.--Not later than 45 days after the date of enactment 
of this Act, the Secretary of Health and Human Services shall seek to 
enter into a contract with the National Academies of Sciences, 
Engineering, and Medicine (referred to in this section as the 
``National Academies'') to conduct a study related to the current 
scientific evidence on the durability of immunity to COVID-19.
    (b) Inclusions.--The study pursuant to the contract under 
subsection (a) shall include--
            (1) an assessment of scientific evidence related to the 
        durability of immunity resulting from SARS-CoV-2 infection, 
        COVID-19 vaccination, or both, including any differences 
        between population groups;
            (2) an assessment of the extent to which the Federal 
        Government makes publicly available the scientific evidence 
        used by relevant Federal departments and agencies to inform 
        public health recommendations related to immunity resulting 
        from SARS-CoV-2 infection and COVID-19 vaccination; and
            (3) a summary of scientific studies and evidence related to 
        SARS-CoV-2 infection-acquired immunity from a sample of other 
        countries or multilateral organizations.
    (c) Report.--Not later than 18 months after the date of enactment 
of this Act, the National Academies shall submit to the Committee on 
Health, Education, Labor, and Pensions of the Senate and the Committee 
on Energy and Commerce of the House of Representatives a report on the 
study pursuant to subsection (a).
    (d) Authorization of Appropriation.--There is authorized to be 
appropriated such sums as may be necessary for fiscal year 2023 to 
carry out this section.
                                 <all>
```